Development of in vitro laboratory models of the tumor immune microenvironment to evaluate quality parameters and specific efficacy of the dendritic cell vaccine
Purpose of the study: development of in vitro laboratory models to evaluate quality parameters and specific efficacy of dendritic cell vaccine (DCV).Material and Methods. Biological samples of malignant tumor patients treated with autologous dendritic cell vaccine (DC) were included into the study....
Saved in:
| Main Authors: | T. L. Nekhaeva, A. B. Danilova, E. I. Fedoros, N. A. Efremova, N. V. Emelyanova, M. L. Blokhina, M. N. Yurova, M. L. Tyndyk, I. A. Baldueva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2023-02-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/2434 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STUDY OF DENDRITIC CELL MIGRATION USING CELL-IQ ANALYSIS SYSTEM
by: T. L. Nekhaeva, et al.
Published: (2018-09-01) -
Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01) -
IN VITRO CELLULAR INTERACTIONS DURING IMMUNE RESPONSE TO T CELLINDEPENDENT TYPE 2 ANTIGENS
by: M. V. Gavrilova, et al.
Published: (2014-07-01) -
D609 Suppresses Antituberculosis Response by Regulating Dendritic Cells Antigen Presentation
by: Honglin Liu, et al.
Published: (2024-12-01) -
Evaluating Nanoparticulate Vaccine Formulations for Effective Antigen Presentation and T-Cell Proliferation Using an In Vitro Overlay Assay
by: Dedeepya Pasupuleti, et al.
Published: (2024-09-01)